查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1291615

下一代糖尿病治療和藥物輸送市場2023-2028年按產品類型、人口統計學（成人人口、兒童人口）、適應症、終端用戶（診斷/診所、重症監護室、家庭保健）和地區分類

Next Generation Diabetes Therapy and Drug Delivery Market by Product Type, Demographic (Adult Population, Child Population ), Indication, End User (Diagnostic/Clinics, Intensive Care Units, Home Healthcare), and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3個工作天內

價格

市場概述：

2022年，全球下一代糖尿病治療和藥物輸送市場規模達到84.1億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到221.4億美元，在2023-2028年期間呈現16.30%的成長率（CAGR）。糖尿病患病率的上升，特別是2型糖尿病，持續的技術進步，以及不斷成長的老年人口，代表了推動市場的一些關鍵因素。

下一代糖尿病治療和給藥程序的重點是以微創的方式將胰島素引入患者體內，以減少頻繁使用針頭造成的皮膚刺激風險。這種對病人友好的方法旨在通過利用包括可穿戴感測器、微型針頭和可吸入胰島素在內的創新技術，有效控制疾病，同時降低醫療成本。先進的療法，如連續葡萄糖監測系統（CGMS）、人工胰腺和胰島素貼片，也被用來改善血糖水平的管理，將糖尿病相關併發症的風險降至最低。此外，該程序便於計算劑量量，即時檢查血糖水平，並將胰島素無痛地送入體內，這反過來又有助於保持劑量時間。這種治療和給藥做法的一些優勢包括改善病人的治療效果，提高治療效率，最大限度地減少病人的糖尿病管理負擔，從而製定更有針對性的治療計劃。

下一代糖尿病治療和藥物輸送市場趨勢：

全球市場主要由糖尿病，特別是2型糖尿病在大眾中的發病率上升所驅動。這可歸因於越來越多的不健康飲食、久坐的生活方式和減少的體育活動。與此相應，根據個人需求、生活方式和治療目標，對個性化和以病人為中心的護理的需求不斷增加，促使產品的吸收率提高。此外，持續的技術進步，如智慧胰島素筆、閉環系統和副作用較少的植入式設備的開發，正在為市場提供動力。除此之外，個人對微創和無痛治療方案的日益重視也是市場的一個重要成長誘因。市場進一步受到醫療保健支出增加的推動，同時也加強了對基於價值的醫療護理解決方案的關注。然而，發展中地區日益成長的成本限制、缺乏意識和產品的差異性較小，正成為市場的主要成長限制因素。相反，政府對預防保健和早期干預的有利計劃和報銷政策的實施正在為市場創造一個積極的前景。除此之外，越來越多的老年人口更容易患慢性病，這對市場產生了有利的影響。其他一些促進市場的因素包括快速的城市化，對傳統糖尿病治療的相關併發症的認識不斷提高，遠程醫療和數位健康解決方案的採用不斷增加，可支配收入水平不斷上升，以及主要參與者進行的廣泛的研究和開發（R&D）活動。

本報告中回答的關鍵問題：

  • 迄今為止，全球下一代糖尿病治療和藥物輸送市場的表現如何，在未來幾年將如何表現？
  • 全球下一代糖尿病治療和藥物輸送市場的驅動因素、限制因素和機會是什麼？
  • 每個驅動因素、限制因素和機會對全球下一代糖尿病治療和給藥市場的影響是什麼？
  • 哪些是關鍵的區域市場？
  • 哪些國家代表了最具吸引力的全球下一代糖尿病治療和給藥市場？
  • 基於產品類型的市場細分是什麼？
  • 在全球下一代糖尿病治療和給藥市場中，哪種產品類型最有吸引力？
  • 基於人口統計學的市場細分是什麼？
  • 在全球下一代糖尿病治療和給藥市場中，哪個人口群體最具吸引力？
  • 基於適應症的市場細分是什麼？
  • 在全球下一代糖尿病治療和給藥市場中，哪一個是最有吸引力的適應症？
  • 基於終端用戶的市場細分是什麼？
  • 在全球下一代糖尿病治療和給藥市場中，哪一個是最有吸引力的終端用戶？
  • 全球下一代糖尿病治療和給藥市場的競爭結構是什麼？
  • 誰是全球下一代糖尿病治療和給藥市場的主要參與者/公司？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球下一代糖尿病治療和藥物輸送市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按產品類型分類的市場

  • 可吸入胰島素
    • 市場趨勢
    • 市場預測
  • 口服胰島素
    • 市場趨勢
    • 市場預測
  • 胰島素貼劑
    • 市場趨勢
    • 市場預測
  • 胰島素治療儀系統
    • 市場趨勢
    • 市場預測
  • 人工胰腺
    • 市場趨勢
    • 市場預測

第7章：按人口統計學分類的市場

  • 成人人口（大於14歲）
    • 市場趨勢
    • 市場預測
  • 兒童人口（14歲）
    • 市場趨勢
    • 市場預測

第8章：按適應症分類的市場

  • 1型糖尿病
    • 市場趨勢
    • 市場預測
  • 2型糖尿病
    • 市場趨勢
    • 市場預測

第九章：按終端用戶分類的市場

  • 診斷/診所
    • 市場趨勢
    • 市場預測
  • 重症監護室（ICU）
    • 市場趨勢
    • 市場預測
  • 家庭保健
    • 市場趨勢
    • 市場預測

第十章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十一章：驅動因素、限制因素和機會

  • 概述
  • 驅動因素
  • 限制因素
  • 機會

第十二章：價值鏈分析

第十三章：波特斯五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十四章：價格分析

第十五章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的簡介
    • Abbott Laboratories
    • Dexcom Inc.
    • Eli Lilly and Company
    • Enteris BioPharma Inc. (Swk Holdings Corporation)
    • GlySens Incorporated
    • MannKind Corporation
    • Medtronic plc
    • Sanofi
    • Senseonics

請注意，這只代表部分公司的名單，完整的名單已在報告中提供。

Product Code: SR112023A7519

Market Overview:

The global next generation diabetes therapy and drug delivery market size reached US$ 8.41 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.14 Billion by 2028, exhibiting a growth rate (CAGR) of 16.30% during 2023-2028. The rising prevalence of diabetes, particularly type-2 diabetes, continual technological advancements, and the growing geriatric population represent some of the key factors driving the market.

Next generation diabetes therapy and drug delivery procedure focuses on the introduction of insulin into the patient's body in a minimally invasive manner to reduce the risk of skin irritation from frequent needle usage. This patient-friendly approach aims to effectively manage the disease while reducing healthcare costs by utilizing innovative technologies including wearable sensors, micro-needles, and inhalable insulin. Advanced therapies, such as continuous glucose monitoring systems (CGMS), artificial pancreas, and insulin patches, are also employed to improve blood sugar level management that minimize the risks of diabetic-related complications. In addition, the procedure facilitates easy calculation of the dose volume, checking the blood glucose levels in real-time, and delivers insulin into the body painlessly, which, in turn, helps to maintain the dosage time. Some of the advantages of this therapy and drug delivery practice includes improved patient outcomes, enhanced treatment efficiency, and minimized burden of diabetes management for patients, leading to more targeted treatment plans.

Next Generation Diabetes Therapy and Drug Delivery Market Trends:

The global market is primarily driven by the rising prevalence of diabetes, particularly type-2 diabetes, among the masses. This can be attributed to the increasing consumption of unhealthy diets, sedentary lifestyles and reduced physical activity. In line with this, the augmenting demand for personalized and patient-centric care according to individual needs, lifestyle, and treatment goals is resulting in a higher product uptake. Moreover, continual technological advancements, such as the development of smart insulin pens, closed-loop systems, and implantable devices with fewer side effects, is providing an impetus to the market. In addition to this, the increasing emphasis on minimally invasive and pain-free treatment options among individuals is also acting as a significant growth-inducing factor for the market. The market is further driven by the increasing healthcare expenditure, along with an enhanced focus on value-based medical care solutions.  However, the growing cost restrains, lack of awareness and less variability in products in the developing regions are acting as major growth-restraining factors for the market. Conversely, the implementation of favorable government initiatives and reimbursement policies regarding preventive healthcare and early intervention is creating a positive outlook for the market. Apart from this, the growing geriatric population that is more susceptible to developing chronic diseases is impacting the market favorably. Some of the other factors contributing to the market include rapid urbanization, increasing awareness regarding the associated complications of traditional diabetes treatment, rising adoption of telehealth and digital health solutions, inflating disposable income levels and extensive research and development (R&D) activities conducted by key players.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global next generation diabetes therapy and drug delivery market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product type, demographic, indication, and end user. 

Product Type Insights:

  • Inhalable Insulin
  • Oral Insulin
  • Insulin Patches
  • CGM Systems
  • Artificial Pancreas

The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the product type. This includes inhalable insulin, oral insulin, insulin patches, CGM systems, and artificial pancreas. According to the report, CGM systems represented the largest segment.

Demographic Insights:

  • Adult Population (>14 Years)
  • Child Population (14 Years)

The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the demographic. This includes adult population (>14 years) and child population (14 years). According to the report, adult population (>14 years) represented the largest segment.

Indication Insights:

  • Type 1 diabetes
  • Type 2 diabetes

The report has provided a detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the indication. This includes type 1 diabetes, type 2 diabetes. According to the report, type 2 diabetes represented the largest segment.

End User Insights:

  • Diagnostic/Clinics
  • Intensive Care Units (ICUs)
  • Home Healthcare

A detailed breakup and analysis of the global next generation diabetes therapy and drug delivery market based on the end user has also been provided in the report. This includes diagnostic/clinics, intensive care units (ICUs), and home healthcare. According to the report, diagnostic/clinics accounted for the largest market share.

Regional Insights:

  • North America 
    • United States 
    • Canada 
  • Asia Pacific 
    • China 
    • Japan 
    • India 
    • South Korea 
    • Australia 
    • Indonesia 
    • Others 
  • Europe 
    • Germany 
    • France 
    • United Kingdom 
    • Italy 
    • Spain
    • Russia
    • Others 
  • Latin America 
    • Brazil 
    • Mexico 
    • Others 
  • Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for next generation diabetes therapy and drug delivery. Some of the factors driving the North America next generation diabetes therapy and drug delivery market included the aging population, continual technological advancements, high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global next generation diabetes therapy and drug delivery market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abbott Laboratories, Dexcom Inc., Eli Lilly and Company, Enteris BioPharma Inc. (Swk Holdings Corporation), GlySens Incorporated, MannKind Corporation, Medtronic plc, Sanofi, Senseonics, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report. 

Key Questions Answered in This Report:

  • How has the global next generation diabetes therapy and drug delivery market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global next generation diabetes therapy and drug delivery market?
  • What is the impact of each driver, restraint, and opportunity on the global next generation diabetes therapy and drug delivery market?
  • What are the key regional markets?
  • Which countries represent the most attractive global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the product type? 
  • Which is the most attractive product type in the global next generation diabetes therapy and drug delivery market? 
  • What is the breakup of the market based on the demographic? 
  • Which is the most attractive demographic in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the global next generation diabetes therapy and drug delivery market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the global next generation diabetes therapy and drug delivery market? 
  • What is the competitive structure of the global next generation diabetes therapy and drug delivery market?
  • Who are the key players/companies in the global next generation diabetes therapy and drug delivery market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Next Generation Diabetes Therapy and Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Inhalable Insulin
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Oral Insulin
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Insulin Patches
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 CGM Systems
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Artificial Pancreas
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Demographic

  • 7.1 Adult Population (>14 Years)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Child Population (14 Years)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Indication

  • 8.1 Type 1 Diabetes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type 2 Diabetes
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Diagnostic/Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Intensive Care Units (ICUs)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Home Healthcare
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Dexcom Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Eli Lilly and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Enteris BioPharma Inc. (Swk Holdings Corporation)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlySens Incorporated
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 MannKind Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Sanofi
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Senseonics
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

  • Figure 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Demographic (in %), 2022
  • Figure 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Indication (in %), 2022
  • Figure 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Next Generation Diabetes Therapy and Drug Delivery (Inhalable Insulin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Next Generation Diabetes Therapy and Drug Delivery (Oral Insulin) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Next Generation Diabetes Therapy and Drug Delivery (Insulin Patches) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Next Generation Diabetes Therapy and Drug Delivery (CGM Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Next Generation Diabetes Therapy and Drug Delivery (Artificial Pancreas) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Next Generation Diabetes Therapy and Drug Delivery (Adult Population (>14 Years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Next Generation Diabetes Therapy and Drug Delivery (Child Population (14 Years)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 1 Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Next Generation Diabetes Therapy and Drug Delivery (Type 2 Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Next Generation Diabetes Therapy and Drug Delivery (Diagnostic/Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Next Generation Diabetes Therapy and Drug Delivery (Intensive Care Units (ICUs)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Next Generation Diabetes Therapy and Drug Delivery (Home Healthcare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: North America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: North America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: United States: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: United States: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Canada: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Canada: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Asia-Pacific: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: China: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: China: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Japan: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Japan: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: India: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: India: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: South Korea: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Australia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Australia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Indonesia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Europe: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Europe: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Germany: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Germany: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: France: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: France: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: United Kingdom: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Italy: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Italy: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Spain: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Spain: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Russia: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Russia: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Latin America: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Brazil: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Mexico: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Others: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Others: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market: Breakup by Country (in %), 2022
  • Figure 81: Middle East and Africa: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Drivers, Restraints, and Opportunities
  • Figure 83: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Value Chain Analysis
  • Figure 84: Global: Next Generation Diabetes Therapy and Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Demographic (in Million US$), 2023-2028
  • Table 4: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 5: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Next Generation Diabetes Therapy and Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Competitive Structure
  • Table 8: Global: Next Generation Diabetes Therapy and Drug Delivery Market: Key Players